Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2010 Jun 26;20(2):155–161. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.012

Table 1.

Participants’ characteristics for all individuals combined and dichotomized by <58 and ≥58 years of age

Characteristics* All individuals <58 yrs ≥58 yrs
Participant numbers 2,499 1,230 1,269
Sex, % male 45 45 45
Age (yrs) 58±10 50±5 66±6
BMI (kg/m2) 27.9±5.2 27.9±5.5 27.8±4.9
Plasma tHcy (nmol/ml)
 All individuals 9.9±3.7 9.4±3.6 10.4±3.8
 Males 10.7±4.0 10.4±3.9 11.1±4.1
 Females 9.2±3.3 8.6±3.1 9.8±3.4
ICA/bulb-IMT (mm) 1.35±0.77 1.10±0.57 1.59±0.86
CCA-IMT (mm) 0.60±0.13 0.55±0.11 0.65±0.14
SBP (mm Hg) 128±19 121±16 135±19
Plasma total cholesterol (mg/dL) 206±37 202±37 209±37
Plasma HDL cholesterol (mg/dL) 52±16 52±15 52±17
Total:HDL cholesterol ratio 4.3±1.5 4.3±1.5 4.4±1.4
Serum creatinine (μmol/L) 101.9±19.0 100.1±16.1 103.5±21.3
Current smoker (%) 15 18 11
Diabetes (%) 8 5 11
Blood pressure treatment (%) 25 15 36
*

All characteristics and measures are from the 6th examination cycle of the Framingham Offspring Study, except plasma total homocysteine levels which are from the 5th examination cycle.

Means ± Standard Deviation.

Appreviations: tHcy=total homocysteine; BMI=Body Mass Index; ICA/bulb-IMT=Internal Carotid Artery/bulb-Intima Media Thickness; CCA-IMT=Common Carotid Artery-Intima Media Thickness; SBP=Systolic Blood Pressure; HDL=High Density Lipoprotein.